Cisplatin or Carboplatin Clinical Trials

3 actively recruiting trials

▲ +1 trial since May 2026

Also known as: Cisplatin, carboplatin

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 1

Top Sponsors

Shanghai Junshi Bioscience Co., Ltd.1
Shanghai JMT-Bio Inc.1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1

Indications

Cancer3
Lung Cancer2
Head Neck Cancer1
Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor1
Head and Neck Squamous Cell Carcinoma (HNSCC)1

Other3 trials

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

Phase 1

A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs

Phase 3

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.